Improving Outcomes for All
Meaningful Impact, Backed By Data
Paradigm Health's clinical research platform combines a global network of care providers with the technology needed to overcome logistical and geographical barriers. From North America to East Asia, we're doing our part to marry critical research and quality care in one seamless journey.
Creating Tangible Outcomes
Pre-Screen Locations Before Paradigm Health
Pre-Screen Locations After Paradigm Health
1
Making an Impact
Expanding Patient Access
Altru Health System Increased Patient Enrollment from 4% to 11% of its Oncology Population
Pre-screening increased from 10,200 annual patient visits within Altru Cancer Center to over 21,200 cancer patient visits across the health system
“Altru Health System historically enrolled four percent of our cancer patient population in clinical trials. Our partnership with Paradigm Health and our Research Department’s implementation of industry leading best practices increased this enrollment to 11% of the population. This has a profound impact on patients’ lives in a rural community that otherwise would not have access to clinical research as a care option.”
Ashlee Dagoberg, PT, DPT
Manager of Research Program, Altru Health System
Improving Diversity and Inclusion
CEO Roundtable on Cancer and Paradigm Health Partner to Launch PACT Collective to Expand Clinical Trial Access and Diversity
Paradigm Health will help design trials to maximize inclusiveness, streamline recruitment with AI-based screening tools, and activate trials at health provider organizations with existing infrastructure and expertise to support underrepresented patients.
Accelerating Global Trials
First-of-its Kind Collaboration to Transform Clinical Trials in Israel
Together, Sheba Medical Center, ARC Innovation and Paradigm Health have launched a collaboration to transform clinical trials with an AI-driven platform that can be deployed at Sheba to streamline their trials, and scale them to any research site throughout Israel.
Paradigm Health Partners with Fujitsu to Solve Clinical Trials in Japan
The collaboration reduces the administrative burden of clinical trial participation for Japanese hospitals, expands patient access, and provides global pharmaceutical companies with a streamlined path to world-class hospitals to accelerate the development of new therapies.
Increasing Patient Enrollment
Highlands Oncology Increased Clinical Trial Participation by 45%
All patients under care at Highlands are now considered for clinical research as a care option alongside the best available standard of care throughout their treatment journey.
Improving Screening Accuracy
OpenAI Highlights Paradigm Health’s Innovative Use of GPT-4 to Improve Patient Access to Clinical Trials
10% more accurate than state of the art machine learning models in 90% less expert clinician time
“The accuracy of OpenAI was better than our existing deployment and optimization of industry best-practice expert-trained models, and it was sometimes better than our trained clinicians. The more complex the information, and the more different places that information sat, the better GPT-4 was.”
Jonathan Hirsch
Chief Strategy and Growth Officer, Paradigm Health
